Management of influenza: updated Swedish guidelines for antiviral treatment

Westin, JohanUniv Gothenburg, Inst Biomed, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden.;Swedish Reference Grp Antiviral Therapy RAV, Stockholm, Sweden.,Sahlgrenska Academy (author)

Management of influenza : updated Swedish guidelines for antiviral treatment

Influenza causes seasonal epidemics of respiratory infection in all parts of the world. Manifestations of influenza range from mild upper to severe lower respiratory tract infection. Medical risk groups are defined by factors predisposing for development of severe disease and are recommended annual vaccination as a protective measure. The previous Swedish treatment guidelines for influenza were issued in 2011, and a review of current evidence was deemed relevant. An important reason to revisit the guidelines is the recent approval of a novel drug for influenza treatment, baloxavir. Updated Swedish evidence-based guidelines created by a group of experts from various research areas, for the management of influenza are presented here. The work has been made in collaboration with the Public Health Agency of Sweden and the Swedish Reference Group for AntiViral therapy (RAV). The updated guidelines include guidelines for diagnostics, treatment and prophylaxis in special groups, including management of pregnant women and children with influenza. A new section about infection control has been added. Pharmacological treatment is covered in detail with regards to indication and dosage. Additionally, drug resistance and environmental aspects are discussed.

Andersson, EmmiPubl Hlth Agcy, Unit Lab Virus & Vaccine Surveillance, Solna, Sweden. (author)
Bengner, MalinReg Jönköping Cty, Off Control Communicable Dis, Jönköping, Sweden. (author)
Berggren, AnnaStockholm County Council,Karolinska University Hospital (author)
Brytting, MiaPubl Hlth Agcy, Unit Lab Virus & Vaccine Surveillance, Solna, Sweden.,Public Health Agency of Sweden (author)
Ernstad, Erica GinstromUniv Gothenburg, Sahlgrenska Univ Hosp, Inst Clin Sci Sahlgrenska Acad, Dept Obstet & Gynaecol, Gothenburg, Sweden.,Sahlgrenska Academy (author)
Nilsson, Anna C.Lund University,Lunds universitet,Klinisk infektionsmedicin,Forskargrupper vid Lunds universitet,Clinical infection medicine,Lund University Research Groups(Swepub:lu)med-ann (author)
Wahlloef, MartinaUniv Gothenburg, Inst Biomed, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden.;Sahlgrens Univ Hosp, Dept Infect Dis, Reg Vastra Gotaland, Gothenburg, Sweden.,Sahlgrenska Academy,Sahlgrenska University Hospital (author)
Westman, Gabriel,1977-Uppsala University,Uppsala universitet,Infektionsmedicin,Swedish Med Prod Agcy, Uppsala, Sweden.,Swedish medical products agency(Swepub:uu)gawes21 (author)
Furberg, MariaSwedish Med Prod Agcy, Uppsala, Sweden.,Swedish medical products agency (author)
Univ Gothenburg, Inst Biomed, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden.;Swedish Reference Grp Antiviral Therapy RAV, Stockholm, Sweden.Sahlgrenska Academy (creator_code:org_t)

In:Infectious Diseases: Taylor & Francis Group55:10, s. 725-7372374-42352374-4243

By the author/editor: Westin, Johan; Andersson, Emmi; Bengner, Malin; Berggren, Anna; Brytting, Mia; Ernstad, Erica G ...; show more...; Nilsson, Anna C.; Wahlloef, Martin ...; Westman, Gabriel ...; Furberg, Maria; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Infectious Medic ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.